West Pharmaceutical Services Income from Continuous Operations 2010-2024 | WST

West Pharmaceutical Services income from continuous operations for the twelve months ending September 30, 2024 was $0.500B, a 10.69% decline year-over-year.

  • West Pharmaceutical Services annual income from continuous operations for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual income from continuous operations for 2022 was $0.586B, a 11.47% decline from 2021.
  • West Pharmaceutical Services annual income from continuous operations for 2021 was $0.662B, a 91.16% increase from 2020.

West Pharmaceutical Services Income from Continuous Operations 2010-2024 | WST

  • West Pharmaceutical Services annual income from continuous operations for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual income from continuous operations for 2022 was $0.586B, a 11.47% decline from 2021.
  • West Pharmaceutical Services annual income from continuous operations for 2021 was $0.662B, a 91.16% increase from 2020.